Position in RPRX
as of Jun 30, 2026
· filed Aug 6, 2026
Position Value
$7,401
+$1,069 QoQ
Shares Held
132
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#590
of 646 holders
Holding Since
Mar 2025
6 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in RPRX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Clearstead Trust, LLC holds $1,415,355 across 17 Biotechnology names. RPRX ranks #8 (0.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
3,940 | $1,186,058 | |
| 2 | ENTA |
Enanta Pharmaceuticals Inc
|
5,064 | $73,833 | |
| 3 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
116 | $57,620 | |
| 4 | INCY |
Incyte Corp
|
141 | $15,983 | |
| 5 | JAZZ |
Jazz Pharmaceuticals plc
|
63 | $15,181 | |
| 6 | RVMD |
Revolution Medicines, Inc.
|
80 | $14,982 | |
| 7 | ROIV |
Roivant Sciences Ltd.
|
228 | $8,068 | |
| 8 | RPRX |
Royalty Pharma plc
This page
|
132 | $7,401 |
All Filings in RPRX
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $7,401 | 132 | Shares | Sole | 2026-08-06 | |
| 2026-03-31 | $6,332 | 132 | Shares | Sole | 2026-05-06 | |
| 2025-12-31 | $5,100 | 132 | Shares | Sole | 2026-02-09 | |
| 2025-09-30 | $6,703 | 190 | Shares | Sole | 2025-11-10 | |
| 2025-06-30 | $4,755 | 132 | Shares | Sole | 2025-08-08 | |
| 2025-03-31 | $3,081 | 99 | Shares | Sole | 2025-05-09 | |
| No filing history on record for this holder in this stock. | ||||||